Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients

Update Il y a 5 ans
Reference: NCT01578213

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to assess the capability of the dPCR technique to predict the absence of disease relapses after imatinib discontinuation in CML patients with negative Q-RT-PCR results for longer than 18 months.


Inclusion criteria

  • Chronic myeloid leukemia

Links